Vocal Biomarkers in Cardiac Rhythm Management and Remote Patient Monitoring
Vocal Biomarkers in Cardiac Rhythm Management and Remote Patient Monitoring: EVOCAL Health discusses scientific findings
top of page
Breaking New Ground with Digital Biomarkers (IQVIA)
Hamburg (Germany), March 15, 2022: With the relentless rise of digital health, we are witnessing the emergence of digital biomarkers –...
The year in cardiovascular medicine: digital health and innovation (European Heart Journal, 2022)
Hamburg (Germany), March 4, 2022: The role of machine learning in the development of prognostic models for early warning systems and risk...
Role of new digital technologies and telemedicine in pulmonary rehabilitation (Wien Klin Wochenschr)
Hamburg (Germany)/ Vienna (Austria), March 1, 2022: The use of modern digital technology in pulmonary rehabilitation offers unprecedented...
Traditional and Digital Biomarkers: Two Worlds Apart? (Karger)
Hamburg (Germany), February 24, 2022: Biomarkers are an integral part of biomedical research and clinical practice. As digital devices...
Voice for Health: The Use of Vocal Biomarkers from Research to Clinical Practice
Hamburg (Germany), February 02, 2022: The evolution of voice technology in research and clinical practice, audio signal analysis, and...
From facility to home: How healthcare could shift by 2025 (McKinsey & Company)
Hamburg (Germany), December 21, 2021: Reimagining health in the home care environment will require patient centric and interconnected...
EVOCAL Health Releases Cloud-Based Vocal Biomarker Development Platform
EVOCAL Health Releases Cloud-Based Vocal Biomarker Development Platform: SaaS-Platform To Leverage the Potential Of Human Voice Biomarkers
EVOCAL Health Receives CE Certification For Vocal Biomarker Technology
EVOCAL Health receives CE certification for its first commercial product with Vocal Biomarker technology.
bottom of page